Patents by Inventor Juliano Timm

Juliano Timm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7601350
    Abstract: Purified antibodies that bind to M. tuberculosis ERP protein are disclosed. In one embodiment, a purified antibody, which binds specifically with a polypeptide comprising SEQ ID NO: 39 or SEQ ID NO: 41 is provided. In some embodiments the polypeptide has a theoretical molecular weight of about 28 kDa. In other embodiments the polypeptide has an observed molecular weight of about 36 kDa, as determined by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The purified antibody may be a monoclonal or a polyclonal antibody. Further embodiments provide antibodies that does not bind specifically with M. leprae P28 protein. The antibodies of the invention have many uses including the identification of M. tuberculosis.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: October 13, 2009
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Publication number: 20060127959
    Abstract: Purified antibodies that bind to M. tuberculosis ERP protein are disclosed. In one a embodiment, a purified antibody, which binds specifically with a polypeptide comprising SEQ ID NO: 39 or SEQ ID NO: 41 is provided. In some embodiments the polypeptide has a theoretical molecular weight of about 28 kDa. In other embodiments the polypeptide has an observed molecular weight of about 36 kDa, as determined by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The purified antibody may be a monoclonal or a polyclonal antibody. Further embodiments provide antibodies that does not bind specifically with M. teprae P28 protein. The antibodies of the invention have many uses including the identification of M. tuberculosis.
    Type: Application
    Filed: January 15, 2003
    Publication date: June 15, 2006
    Applicant: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Patent number: 6565855
    Abstract: Recombinant screening, cloning and/or expression vector characterized in that it replicates in mycobacteria and contains: 1) a mycobacteria functional replicon, 2) a selection marker, 3) a reporter cassette comprising: a) a multiple cloning site (polylinker), b) a transcription terminator which is active in mycobacteria and is located upstream of the polylinker, and c) a coding nucleotide sequence derived from a gene coding for an expression, export and/or secretion protein marker, the nucleotide sequence being deprived of its initiation codon and its regulating sequences. This vector is used for identification and expression of exporter polypeptides, such as the Mycobacterium tuberculosis P28 antigen.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: May 20, 2003
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Patent number: 6248581
    Abstract: Recombinant screening, cloning and/or expression vector characterized in that it replicates in mycobacteria and contains 1) a mycobacteria functional replicon; 2) a selection marker, 3) a reporter cassette comprising a) a multiple cloning site (polylinker) b) a transcription terminator which is active in mycobacteria and is located upstream of the polylinker, and c) a coding nucleotide sequence derived from a gene coding for an expression, export and/or secretion protein marker, the nucleotide sequence being deprived of its initiation codon and its regulating sequences. This vector is used for identification and expression of exporter polypeptides, such as the Mycobacterium tuberculosis P28 antigen.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: June 19, 2001
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Patent number: 5830457
    Abstract: The present invention relates to a nucleotide sequence characterized in that it is selected amongst the following nucleotide sequences: the sequence of the gene coding for a B-lactamase, or any part of said gene, particularly the sequence between nucleotides 1 and 394 containing the signals for expression of the gene, or the coding sequence comprising nucleotides 395 to 1274, or any sequence hybridizing under stringent conditions with the above sequence. Utilization of B-lactamase as a carrier protein for carrying heterolog epitopes for the preparation of vaccine compositions is also disclosed.
    Type: Grant
    Filed: November 14, 1994
    Date of Patent: November 3, 1998
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Juliano Timm, Joaquim Trias, Colette Duez, Maria-Grazia Perilli, Jean Dusart, Jean-Marie Frere